We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,024.00
Bid: 12,024.00
Ask: 12,028.00
Change: 36.00 (0.30%)
Spread: 4.00 (0.033%)
Open: 12,254.00
High: 12,256.00
Low: 12,018.00
Prev. Close: 11,988.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Jefferies cuts Persimmon; BoA cuts GSK

Mon, 05th Dec 2022 10:00

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

Bank of America cuts Vodafone price target to 130 (140) pence - 'neutral'

----------

Bank of America cuts BT Group price target to 187 (223) pence - 'buy'

----------

Bank of America cuts GSK to 'underperform' (neutral) - price target 1,450 (1,640) pence

----------

Bank of America raises AstraZeneca price target to 14,500 (12,500) pence - 'buy'

----------

Bernstein cuts Reckitt Benckiser price target to 6,100 (6,400) pence - 'market-perform'

----------

Bernstein cuts Unilever to 'market-perform' (outperform) - price target 3,500 (4,280) pence

----------

RBC raises Compass Group price target to 1,625 (1,575) pence - 'underperform'

----------

JPMorgan raises B&M price target to 555 (414) pence - 'overweight'

----------

JPMorgan raises Sainsbury price target to 206 (161) pence - 'underweight'

----------

JPMorgan raises Tesco price target to 270 (240) pence - 'overweight'

----------

Jefferies raises Barratt Developments price target to 452 (356) pence - 'hold'

----------

Jefferies cuts Persimmon to 'hold' (buy) - price target 1,436 (1485) pence

----------

Jefferies raises Taylor Wimpey price target to 124 (105) pence - 'buy'

----------

Jefferies raises Berkeley Group price target to 4,554 (4,330) pence - 'buy'

----------

Jefferies raises CRH price target to 51.60 (50.30) EUR - 'buy'

----------

Jefferies cuts Spirax-Sarco price target to 9,910 (11,460) pence - 'underperform'

----------

FTSE 250

----------

Bank of America raises Helios Towers price target to 180 (175) pence - 'buy'

----------

Morgan Stanley cuts Hays price target to 145 (146) pence - 'overweight'

----------

Morgan Stanley cuts PageGroup to 'equal-weight' (overweight) - price target 505 (510) pence

----------

UBS raises easyJet price target to 600 (565) pence - 'buy'

----------

Jefferies raises Travis Perkins price target to 931 (811) pence - 'hold'

----------

Jefferies raises Redrow price target to 592 (491) pence - 'buy'

----------

Jefferies raises Crest Nicholson price target to 278 (229) pence - 'buy'

----------

Jefferies raises Vistry price target to 829 (744) pence - 'buy'

----------

Jefferies raises Bellway to 'buy' (hold) - price target 2,458 (1,928) pence

----------

SMALL CAP

----------

Citigroup cuts Gamma Communications price target to 1,320 (1,650) pence - 'buy'

----------

Berenberg raises Tharisa price target to 260 (240) pence - 'buy'

----------

Deutsche Bank cuts Ferguson price target to 9,630 (9,960) pence - 'hold'

----------

Barclays raises AIB price target to 3.80 (3.40) EUR - 'equal weight'

----------

Jefferies cuts Watkin Jones to 'hold' (buy) - price target 111 (225) pence

----------

Jefferies cuts Kingspan to 'underperform' (hold) - price target 45.90 (63.60) EUR

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
Today 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
Today 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
Today 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
Today 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.